U-M and MSU researchers have joined together to develop novel compounds for the treatment of scleroderma, supported by a three-year, $2M award from the National Institutes of Health (NIH). "Dr. [Scott] Larsen is a member of a team of basic science and clinician researchers at U-M and MSU who have joined forces to further the development of novel compounds for the treatment of scleroderma. The initial discovery was made by Dr. Richard Neubig, chair of the pharmacology and toxicology department at Michigan State University, via high-throughput screening at the Center for Chemical Genomics at the U-M Life Sciences Institute."
Congratulations to the Spring 2014 graduates of our MS in Pharmacology & Toxicology program.
"[EAST] LANSING, Mich. - Groundbreaking research is being done at Michigan State University for a debilitating disease that hardens skin. "
Each year the Society of Toxicology presents awards to distinguished toxicologists and students from around the world. At their 2014 annual meeting, a diverse group of faculty and students from Michigan State University were selected
From MSU Today 4/3/2014 - "Scleroderma is a rare and often fatal disease, causing the thickening of tissue, that currently lacks a cure and any effective treatments. A group of researchers, including a Michigan State University professor, is looking to change that."